METOPROLOL TARTRATE | A077739 | AUROBINDO PHARMA LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Hyman, Phelps & McNamara P.C. FDA-2021-P-0124 · 8 docket documents On January 25, 2021, Hyman, Phelps & McNamara P.C. filed a suitability petition under Section 505(j)(2)(C) of the Federal Food, Drug and Cosmetic Act requesting that the FDA declare Metoprolol Tartrate Tablets, 12.5 mg, suitable for submission as an abbreviated new drug application (ANDA), with the | Suitability | 2021-01-28 | Withdrawn | Hyman, Phelps & McNamara P.C. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.0282
per ea
Lowest NADAC/Unit
$0.0170
per ea
Brand NDCs
0
Generic NDCs
17
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 57237010201METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
| 62584026701METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
| 68645019159METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
| 65862006401METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
| 65862006499METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
| 57237010299METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
Showing 6 of 17 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.